I have been running tirzepatide for three weeks and the honest summary is that the effect is smaller than the internet suggests and real.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took three weeks to be sure.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
The animal data is stronger than the human data and the human data is not nothing, it is just small.
Muscle loss is the thing to watch, which means protein and resistance training rather than appetite alone.
Willing to accept that my own experience is the weakest evidence in the room.
Narrow conclusion.
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation. Sulphur burps was my main issue with tirzepatide too.
Stupid question: how do you know whether what is in the vial matches the label at all?
Baseline first.
Cold storage, light protection, date on the vial. Boring, removes half the variables.
I would take the narrow conclusion. Broad ones are more interesting and less true.
Where does the human data stop and the extrapolation begin? That is the whole thread. Same for me with tirzepatide, unfortunately.
Sleep, food, or the compound? Yes.